Patent Application
Utility
App. No. 17/679,841
· Confirmation No. 8235
DETECTION OF DYSTROGLYCAN
Inventor:
Hector M. RODRIGUEZ
Applicant:
ML Bio Solutions Inc.
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2025-09-02 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2025-09-02 | C.AD |
Change of Address | 1 | View | |
| 2024-05-24 | ABN |
Abandonment | 2 | View | |
| 2023-11-28 | EXIN |
Examiner Interview Summary Record (PTOL - 413) | 2 | View | |
| 2023-09-21 | CTNF |
Non-Final Rejection | 25 | View | |
| 2023-09-21 | 892 |
List of references cited by examiner | 2 | View | |
| 2023-09-21 | SRFW |
Search information including classification, databases and other search related notes | 2 | View | |
| 2023-09-21 | SRNT |
Examiner's search strategy and results | 5 | View | |
| 2023-09-21 | 1449 |
List of References cited by applicant and considered by examiner | 2 | View | |
| 2023-09-21 | SRNT |
Examiner's search strategy and results | 2 | View | |
| 2022-09-15 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2022-09-09 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 2 | View | |
| 2022-09-09 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2022-09-09 | FOR |
Foreign Reference | 94 | View | |
| 2022-09-09 | TRAN.LET |
Transmittal Letter | 5 | View | |
| 2022-08-24 | OATH |
Oath or Declaration filed | 1 | View | |
| 2022-08-24 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2022-08-23 | OATH |
Oath or Declaration filed | 9 | View | |
| 2022-06-09 | NTC.PUB.DATE |
Notice of New or Revised Publication Date | 1 | View | |
| 2022-06-06 | M327 |
Miscellaneous Communication to Applicant - No Action Count | 1 | View | |
| 2022-06-06 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2022-06-06 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2022-02-24 | PA.. |
Power of Attorney | 2 | View | |
| 2022-02-24 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2022-02-24 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2022-02-24 | ADS |
Application Data Sheet | 8 | View | |
| 2022-02-24 | SPEC |
Specification | 36 | View | |
| 2022-02-24 | CLM |
Claims | 3 | View | |
| 2022-02-24 | ABST |
Abstract | 1 | View | |
| 2022-02-24 | DRW.NONBW |
Drawings-other than black and white line drawings | 13 | View | |
| 2022-02-24 | SCORE |
Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) | 1 | View | |
| 2022-02-24 | DRW.SUPP |
Drawings-black and white line and/or other drawings | — | View |
Inventors
Hector M. RODRIGUEZ
San Bruno, CA
Attorneys & Agents of Record
Classification
USPC
435/7.21
G01N33/6893
C07K16/18
G01N2333/47
G01N2333/78
Prosecution
- Examiner
- EMCH, GREGORY S
- Art Unit
- 1678
- Docket No.
- MLBI-005/01US 337361-2029
- Confirmation No.
- 8235
Publication
- Pub. No.
- US20220291236A1
- Pub. Date
- 2022-09-15
BRIDGEBIO PHARMA, INC.,
QED THERAPEUTICS, INC.,
EIDOS THERAPEUTICS, INC.,
ML BIO SOLUTIONS INC.,
CALCILYTIX THERAPEUTICS INC.,
ADRENAS THERAPEUTICS INC.,
PHOENIX TISSUE REPAIR, INC.,
NAVIRE PHARMA, INC.,
VENTHERA, INC.,
MOLECULAR SKIN THERAPEUTICS, INC.,
CANTERO THERAPEUTICS, INC.,
COA THERAPEUTICS, INC.,
PORTAL THERAPEUTICS, INC.,
BRIDGEBIO GENE THERAPY RESEARCH, INC.,
FERRO THERAPEUTICS, INC.
RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL
Recorded 2025-03-05
from
ADRENAS THERAPEUTICS INC.,
BRIDGEBIO GENE THERAPY RESEARCH, INC.,
BRIDGEBIO PHARMA, INC.,
CALCILYTIX THERAPEUTICS INC.,
CANTERO THERAPEUTICS, INC.,
COA THERAPEUTICS, INC.,
EIDOS THERAPEUTICS, INC.,
FERRO THERAPEUTICS, INC.,
ML BIO SOLUTIONS INC.,
MOLECULAR SKIN THERAPEUTICS, INC.,
NAVIRE PHARMA, INC.,
PHOENIX TISSUE REPAIR, INC.,
PORTAL THERAPEUTICS, INC.,
QED THERAPEUTICS, INC.,
SUB21, INC.,
THERAS, INC.,
VENTHERA, INC.
SECURITY INTEREST
Recorded 2024-01-19
from
ADRENAS THERAPEUTICS INC.,
BRIDGEBIO GENE THERAPY RESEARCH, INC.,
CALCILYTIX THERAPEUTICS INC.,
CANTERO THERAPEUTICS, INC.,
COA THERAPEUTICS, INC.,
FERRO THERAPEUTICS, INC.,
MOLECULAR SKIN THERAPEUTICS, INC.,
NAVIRE PHARMA, INC.,
PHOENIX TISSUE REPAIR, INC.,
PORTAL THERAPEUTICS, INC.,
SUB21, INC.,
VENTHERA, INC.
SECURITY INTEREST
Recorded 2024-01-17
from
RODRIGUEZ, HECTOR M.
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2022-08-23
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 17/679,841
- Filed
- 2022-02-24
- Pub. No.
- US20220291236A1
- Examiner
- EMCH, GREGORY S
- Art Unit
- 1678
External Links